<DOC>
	<DOC>NCT00404937</DOC>
	<brief_summary>The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation</brief_summary>
	<brief_title>Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Patients scheduled for cataract extraction Under 18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>